Unlocking Pharmaceutical Success with Zetasizer: Practical Insights & Key Considerations

Webinar Series: Zetasizer Masterclass – Edition 2 (available on-demand)

In today’s fast-paced pharmaceutical & biotech landscape, advanced particle size and surface charge measurements are more important than ever. Whether you’re developing nano-formulations, monitoring QC, or troubleshooting complex colloidal systems – having reliable, reproducible measurement workflows is critical.

That’s exactly why our Zetasizer Masterclass – Edition 2 is so relevant. Designed especially for users of the Zetasizer Advance series (and anyone working with DLS/Electrophoretic Light Scattering) the series delivers practical, applied guidance across method development, regulatory compliance and real-world case studies.

What’s included

Here are the four key sessions now available on-demand:

1. DLS and Zeta potential – Method development with worked examples
   Led by Benjamin Lynch (Application Scientist, Malvern Pananalytical), this session dives deep into setting up robust DLS and ELS methods: choosing measurement settings, accounting for sample concentration effects, and interpreting data with confidence.
2. Practical implications of USP 430
   How can you ensure your DLS workflows align with the United States Pharmacopeia (USP) guidelines? This webinar focuses on USP 430 compliance for DLS using the Zetasizer Advance series, helping you meet regulatory expectations with confidence.
3. Practical implications of USP 432 for zeta potential measurements
   Zeta potential is a key QC/characterisation parameter in many pharma workflows. This session addresses USP 432’s requirements for ELS, offering insight into instrumentation, method development, measurement procedure and data interpretation for zeta potential workflows.
4. Zetasizer – Troubleshooting examples from customers
   Real-world data. Real problems. Real solutions. In this session we work through customer data from both DLS and zeta potential workflows on Zetasizer Advance instruments, identify common pitfalls, and share practical tips to improve confidence in your results.

Why watch now?

• On-demand access: Missed the live webinars? No problem — all sessions are recorded and ready to stream at your convenience.
• Regulatory relevance: With USP 430 and USP 432 covered, these sessions are directly aligned with pharma/biotech compliance needs.
• Applied insights: Beyond theory — you’ll get worked examples and troubleshooting case studies to take back to your lab immediately.
• Instrument-specific guidance: Tailored for the Zetasizer Advance portfolio, meaning you’ll hear context-specific advice rather than generic content.

Who should watch?

• QC/analytical staff in pharmaceutical/biologic organisations using DLS and zeta potential instrumentation
• Method development scientists working on nanoparticle/nanosuspension characterisation
• Lab managers wanting to enhance measurement reliability and regulatory alignment
• Anyone using (or considering) the Zetasizer Advance family of instruments and looking to maximise value, avoid pitfalls and introduce best practice workflows

Don’t miss this opportunity to deepen your understanding of DLS and zeta potential workflows, sharpen your method development approach, and align your measurement strategy with regulatory best practice — all on your own schedule.

Related content

• Advance Your DLS & Zeta Potential Workflows
• Particle Sizing Techniques: Choosing the Right Method for Your Application
• Which cuvette should I use with my Zetasizer?
• PDI from an individual peak in DLS
• D90, D50, D10, and span – for DLS?